haematology
Transfusion medicine

US has jumped the gun on convalescent plasma, critics warn

Australian experts have responded with a mix of caution and scepticism to the US Food and Drug Administration (FDA) emergency authorisation for the use of convalescent plasma to treat COVID-19 patients. While convalescent plasma is a promising therapy for COVID-19, it should still be considered experimental, according to Associate Professor Steven Tong, a Royal Melbourne ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic